Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC.

Int J Mol Sci · 2025 · PMC11900290 · PMID 40076928

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

No significant difference was apparent by the single use of MET-I under condition with NIH3T3 (ratio of CRTC2-luc2:NIH3T3 is 1:2); however, significant therapeutic effect was observed by MET-I in combination with HGFA-I ( Figure 5 E).

also in 290 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.